{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:36Z","timestamp":1792790496011,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019236","name":"Department of Radiology, Weill Cornell Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011326","name":"Shiga University of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.gore.2023.101265","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T18:01:00Z","timestamp":1693764060000},"page":"101265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Locally advanced endometrial cancer with multiple immune-related adverse events coinciding with the complete response to radiotherapy after immune checkpoint inhibitor therapy: A case report"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-8151","authenticated-orcid":false,"given":"Yuji","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukuru","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yoneoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2023.101265_b0005","doi-asserted-by":"crossref","first-page":"106663","DOI":"10.1016\/j.intimp.2020.106663","article-title":"Abscopal effect in radioimmunotherapy","volume":"85","author":"Ashrafizadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.gore.2023.101265_b0010","first-page":"99","article-title":"Primary empty sella syndrome and the prevalence of hormonal dysregulation","volume":"115","author":"Auer","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"issue":"3","key":"10.1016\/j.gore.2023.101265_b0015","doi-asserted-by":"crossref","first-page":"e228135","DOI":"10.1136\/bcr-2018-228135","article-title":"Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancer","volume":"12","author":"Chang","year":"2019","journal-title":"BMJ. Case. Rep."},{"key":"10.1016\/j.gore.2023.101265_b0020","article-title":"Combining concurrent radiotherapy and immunotherapy for synergistic effects in recurrent endometrial cancer - A case report","volume":"44","author":"Chepkemoi","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.gore.2023.101265_b0025","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.gore.2023.101265_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11102-012-0416-6","article-title":"Primary empty sella (PES): a review of 175 cases","volume":"16","author":"Guitelman","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.gore.2023.101265_b0035","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-11-0407","article-title":"CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans","volume":"17","author":"Huang","year":"2011","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.gore.2023.101265_b0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jgf2.616","article-title":"Crowned dens syndrome: A case series of 72 patients at eight teaching hospitals in Japan","volume":"24","author":"Isono","year":"2023","journal-title":"J. Gen. Fam. Med."},{"key":"10.1016\/j.gore.2023.101265_b0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40425-019-0597-x","article-title":"Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare","volume":"7","author":"Kim","year":"2019","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.gore.2023.101265_b0050","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/1097-0142(19901101)66:9<1949::AID-CNCR2820660917>3.0.CO;2-E","article-title":"Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor","volume":"66","author":"Lang","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.gore.2023.101265_b0055","article-title":"A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer","volume":"39","author":"Nagai","year":"2021","journal-title":"Urol. Case. Rep."},{"key":"10.1016\/j.gore.2023.101265_b0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.gore.2023.101265_b0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41416-020-0736-7","article-title":"Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study","volume":"122","author":"Okada","year":"2020","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.gore.2023.101265_b0070","doi-asserted-by":"crossref","first-page":"1832760","DOI":"10.1080\/2162402X.2020.1832760","article-title":"Immunotherapy as sensitizer for local radiotherapy","volume":"9","author":"Vanneste","year":"2020","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.gore.2023.101265_b0075","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00262-020-02803-5","article-title":"Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors","volume":"70","author":"Zhong","year":"2021","journal-title":"Cancer. Immunol. Immunother."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578923001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578923001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:59:32Z","timestamp":1762480772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578923001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":15,"alternative-id":["S2352578923001340"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2023.101265","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locally advanced endometrial cancer with multiple immune-related adverse events coinciding with the complete response to radiotherapy after immune checkpoint inhibitor therapy: A case report","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2023.101265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101265"}}